© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#COVID-19 treatment

Two scientists cooperating while examining antiviral drug in a test tube at laboratory
FDA Approves Remdesivir for Hospitalized COVID-19 Patients
coronavirus
NIH Study Aims To Identify Promising COVID-19 Treatments for Larger Trials
Senior patient in hospital bed nurse
How is COVID-19 treated?
Novel coronavirus SARS-CoV-2

Large Clinical Trial Will Test Combination Monoclonal Antibody Therapy for Mild to Moderate COVID-19

The ACTIV-2 study aims to determine whether neutralizing antibodies reduce the duration of COVID-19 symptoms.
RNA strand

COVID-19 Vaccine’s mRNA Technology Could One Day Help Treat Cancer

Vaccines that stimulate immune responses against cancer using the mRNA technology may be fast-acting and cheap to make.
Antibodies attacking SARS-CoV-2, the coronavirus that causes COVID-19

Experimental Monoclonal Antibody Not Effective for Hospitalized COVID-19 Patients in Phase III Trial

Bamlanivimab did not speed clinical improvement or reduce the time to hospital discharge or sustained recovery.
Antibodies attacking SARS-CoV-2, the coronavirus that causes COVID-19

Investigational COVID-19 Therapeutics To Be Evaluated in Large Clinical Trials

Two Phase III clinical trials are evaluating monoclonal antibodies for people hospitalized with moderate COVID-19.
Remdesivir production.

Baricitinib Plus Remdesivir Shows Promise for Treating COVID-19

The anti-inflammatory and antiviral drug combination reduced time to recovery for people hospitalized with COVID-19.

No More ICU Beds at the Main Public Hospital in the Nation’s Largest County

In Los Angeles County, daily new COVID cases, deaths and hospitalizations have soared beyond their previous highs.

Lie of the Year: The Downplay and Denial of the Coronavirus

Lies infected America in 2020. The very worst were not just damaging, but deadly.
Antibodies attacking SARS-CoV-2, the coronavirus that causes COVID-19

FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19

Agency grants emergency authorization for antibody cocktail given to President Trump.

FDA Authorizes Drug Combination for Treatment of COVID-19

Arthritis drug Olumiant (baricitinib) can be used in combination with remdesivir.

Hydroxychloroquine Does Not Benefit Adults Hospitalized With COVID-19

Recovery and death rates were similar in people treated with the anti-malaria drug or a placebo.
Antibodies attacking SARS-CoV-2, the coronavirus that causes COVID-19

FDA Authorizes Monoclonal Antibody for Treatment of COVID-19

Bamlanivimab is now authorized for nonhospitalized people at high risk for progressing to severe COVID-19.
Remdesivir production.

Remdesivir for COVID-19 Shows No Survival Benefit in Large Study

None of the four drugs tested in the WHO’s Solidarity trial reduced mortality or duration of hospitalization.

Studies Reveal COVID-19 Disparities Among People With Cancer

Black and Latino cancer patients have higher rates of coronavirus infection and hospitalization but are less likely to use telehealth.

Kaletra Still Shows No Benefit for COVID-19

The HIV protease inhibitor combination did not speed recovery or reduce the risk of death in a large study.
Antibodies attacking SARS-CoV-2, the coronavirus that causes COVID-19

Trump Treated With Experimental COVID-19 Antibody Cocktail

The treatment reduced coronavirus levels and sped up recovery in a clinical trial.
Portrait of a senior African American doctor at the hospital wearing a mask

Black Doctors Create a COVID-19 Vaccine Assessment Task Force

The panel’s goal is to ensure that all coronavirus therapeutics approved by the government are safe and effective for African Americans.
Advertisement
Ask COVID Health
Features